Trials / Sponsors / Lpath, Inc.
Lpath, Inc.
Industry · 6 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | A Phase 1a, Double-Blind, Placebo-Controlled, Single Ascending Dose Study to Evaluate Lpathomab in Healthy Vol Healthy Subjects | Phase 1 | 2015-09-01 |
| Terminated | A Phase 2 Study of ASONEP™ to Treat Unresectable and Refractory Renal Cell Carcinoma Renal Cell Carcinoma | Phase 2 | 2013-02-01 |
| Completed | Efficacy and Safety Study of iSONEP With & Without Lucentis/Avastin/Eylea to Treat Wet AMD Exudative Age-related Macular Degeneration | Phase 2 | 2012-08-01 |
| Terminated | iSONEP to Treat Persistent Pigment Epithelial Detachment (PED) in Subjects With Exudative Age-Related Macular Pigment Epithelial Detachment | Phase 1 | 2011-03-01 |
| Unknown | Safety Study of iSONEP (Sonepcizumab/LT1009) to Treat Neovascular Age-related Macular Degeneration Neovascular Age Related Macular Degeneration | Phase 1 | 2008-10-01 |
| Completed | Safety Study of ASONEP (Sonepcizumab/LT1009) to Treat Advanced Solid Tumors Solid Tumors | Phase 1 | 2008-04-01 |